Sign in
CompletedPhase 2

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Key facts

Who runs it
Eric Johnson
Where
Lexington, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
21 people enrolled
Started
8 Dec 2020
Ended
17 Oct 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Saline
  • Ketamine
Record updated
21 September 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • willing to give informed consent
  • scheduled for elective thoracic aorta repair or thoracoabdominal aortic repair
  • requires naloxone continuous infusion for spinal prophylaxis

Who cannot take part

  • allergy to ketamine, acetaminophen, or fentanyl
  • history of hydrocephalus or central nervous system mass
  • diagnosis of schizophrenia
  • incarcerated individuals
  • pregnant or lactating individuals

Where in United States

  • University of Kentucky Medical CenterLexington, United States

About the trial

What the trial wants to find out

The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).

The 2 groups in the trial

  • Standard of CarePlacebo, for comparison

    Participants in this group will receive standard of care as well as a saline infusion during the study period.

    Treatment: Saline

  • Sub-Dissociative KetamineTreatment being tested

    Participants in this group will receive standard of care as well as a continuous ketamine infusion at the induction of anesthesia and for 48 hours postoperatively.

    Treatment: Ketamine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCI
Record updated
21 September 2026